BridgeMD
New treatment option for Tinnitus
Official title Pathophysiology, Psycho-emotional and Cognitive Functioning Associated With Tinnitus
ClinicalTrials.gov ID: NCT04717388
What this study is testing
- What it's testing
- the investigators have recently shown that patients with drug-resistant temporal lobe epilepsy who have undergone brain surgery targeting the medial temporal lobe structures were more likely to develop tinnitus postoperatively. This discovery of a vulnerability to tinnitus associated with medial temporal lobe surgery to eliminate drug-refractory epileptic seizures provides a new clinical model of tinnitus, targeting temporal lobe regions as generators or mediators of this hearing disorder.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Common Criteria for Inclusion :
- Age ≥ 18 years old
- Good written and oral comprehension of the French language
- Person affiliated to a Social Security scheme
- Informed consent signed by the participant
You likely can't join if
- Presence of severe or profound deafness, uni or bilateral.
- Under legal protection (guardianship, curators, etc.) Additional criteria for patients completing visit V2 :
- MRI contraindicated or claustrophobic
- Pregnant or breastfeeding woman.
See the full eligibility criteria
- Common Criteria for Inclusion :
- Age ≥ 18 years old
- Good written and oral comprehension of the French language
- Person affiliated to a Social Security scheme
- Informed consent signed by the participant
- Normal or corrected vision
- Absence of known pre-existing neurological and/or degenerative disorders Group Specific Tinnitus+ Group - Suffering from subjective uni- or bilateral tinnitus, chronic (\>3 months) and stable (no period of remission)...
- Not suffering from tinnitus Group Chir-
- Non epileptic
- Not having undergone surgical treatment of the temporal lobe (including the tonsil)
- Presence of severe or profound deafness, uni or bilateral.
- Under legal protection (guardianship, curators, etc.) Additional criteria for patients completing visit V2 :
- MRI contraindicated or claustrophobic
- Pregnant or breastfeeding woman.
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.